Novartis Vaccine Transaction: Example of GSK's Troubles

Discussion in 'GlaxoSmithKline' started by Anonymous, May 6, 2015 at 12:23 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    After today's training for Meveo and Bexsaro I understand why GSK is hanging on by a thread. We purchased what is said to be the biggest transaction for GSK since the GW and SKB merger. I do not have 1 private account utilizing Menveo. What was Whitty thinking? If I ran my household the way this company has been run I'd be homeless.
     

  2. Anonymous

    Anonymous Guest

    You probably live in a non-choice state
     
  3. Anonymous

    Anonymous Guest

    Novartis is laughing all the way to the bank. They purchased the only growing division at GSK and sold off their crap division. This is the worst deal since they bought Sirtris or rolled out patient first. Who is going to pen the first MBA course text book on how to mess up a fortune 100 company?
     
  4. Anonymous

    Anonymous Guest

    Sirtris is an abomination that Moncef needs to be fired for. What is wrong with GSK management? Why did he buy NVS weak vaccine products? Incredible and demented that he is making $millions.
     
  5. Anonymous

    Anonymous Guest

    At former NVD they were known as "Minveo" and "Bexzero".